JPMorgan Chase & Co’s Connect Biopharma Holdings Limited Ordinary Shares CNTB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121 | Hold |
121
| – | – | ﹤0.01% | 5927 |
|
|
2025
Q1 | $67 | Hold |
121
| – | – | ﹤0.01% | 6054 |
|
|
2024
Q4 | $167 | Hold |
121
| – | – | ﹤0.01% | 5881 |
|
|
2024
Q3 | $172 | Hold |
121
| – | – | ﹤0.01% | 5851 |
|
|
2024
Q2 | $184 | Hold |
121
| – | – | ﹤0.01% | 5773 |
|
|
2024
Q1 | $211 | Hold |
121
| – | – | ﹤0.01% | 5789 |
|
|
2023
Q4 | $143 | Sell |
121
-23,411
| -99% | -$27.7K | ﹤0.01% | 6047 |
|
|
2023
Q3 | $18.2K | Sell |
23,532
-24,840
| -51% | -$19.3K | ﹤0.01% | 5171 |
|
|
2023
Q2 | $53.7K | Sell |
48,372
-30,175
| -38% | -$33.5K | ﹤0.01% | 4842 |
|
|
2023
Q1 | $79K | Buy |
78,547
+72,987
| +1,313% | +$73.4K | ﹤0.01% | 4744 |
|
|
2022
Q4 | $4K | Buy |
5,560
+2,490
| +81% | +$1.79K | ﹤0.01% | 5249 |
|
|
2022
Q3 | $4K | Buy |
3,070
+2,818
| +1,118% | +$3.67K | ﹤0.01% | 5222 |
|
|
2022
Q2 | $0 | Sell |
252
-3,668
| -94% | – | ﹤0.01% | 5617 |
|
|
2022
Q1 | $12K | Buy |
3,920
+1,052
| +37% | +$3.22K | ﹤0.01% | 5356 |
|
|
2021
Q4 | $15K | Buy |
+2,868
| New | +$15K | ﹤0.01% | 5372 |
|